Jeffrey Schlom
0000-0001-7932-4072
4 papers found
Refreshing results…
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
Missing publications? Search for publications with a matching author name.